LOGIN
COA: Extended thromboprophylaxis effective following hip fracture surgery
July 2013
COA: Extended thromboprophylaxis effective following hip fracture surgery
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Extended Venous Thromboembolism (VTE) Prophylaxis after Hip Fracture Surgery with the Ultra-Low-Molecular-Weight Heparin(ULMWH) Semuloparin
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
509 patients who had undergone hip fracture surgery received daily open-label semuloparin injections for 7-10 days following surgery (run-in phase). Afterwards, 469 patients were randomized to receive either semuloparin injections or placebo injections for 19-23 days, to compare the safety and efficacy of extended thromboprophylaxis. Following 24 days results indicated that extended thromboprophyl...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.